CDSCO may waive cough syrups from testing for export to specific countries
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) is considering on a proposal to waive cough syrups from testing for export to specific countries. This move comes in response to a representation from stakeholders who have advocated for such exemption, official sources said on Tuesday.
In May last year, the Directorate General of Foreign Trade, Department of Commerce, Ministry of Commerce and Industry had made it compulsory for cough syrup manufacturers to get samples of their products tested at specified government laboratories from June 1 before getting permission for outbound shipments.
The direction had come after quality concerns were raised globally over cough syrups exported by Indian firms.
Now, the CDSCO, the apex drugs regulatory authority, is examining a proposal to waive the requirement for testing cough syrups being exported to the US, the UK, Canada, the European Union, Japan, Australia, Singapore, Korea and Switzerland at the prescribed laboratory, the sources said.
Further, if a cough syrup is manufactured in a plant or section approved by the regulatory agencies of these countries for any product, it may also be allowed to be exported to any country without testing at the prescribed laboratory, they said.
While the CDSCO is considering waiving the testing requirement, the sources said that according to the latest data, around 353 of 7,087 batches of cough syrups that were tested were found "not of standard quality" on various parameters, including contamination of toxic diethylene glycol and ethylene glycol.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd